Annora Pharma, the formulations subsidiary of Hetero Group and a leading Indian pharmaceutical manufacturer, has expanded its collaboration with AltiusHub to modernise its global drug traceability infrastructure using AI-native serialization, track & trace, and regulatory compliance technology across export operations.
The deployment is designed to improve serialization efficiency by up to 45% while enabling real-time visibility across Annora Pharma’s global drug supply chain operations. The rollout supports regulatory compliance across key export markets, including the US, EU, GCC, LATAM, and ASEAN regions.
As part of the deployment, Annora Pharma aims to establish end-to-end visibility across 100% of serialized drug products within three months, enabling real-time tracking from packaging line to export dispatch.
The unified platform replaces fragmented legacy serialization systems with a centralized traceability infrastructure that supports serialization, aggregation, and multi-market regulatory reporting. It also integrates with Annora Pharma’s existing Level 3 packaging infrastructure.
AltiusHub’s AI-driven analytics and automated exception management capabilities help improve operational efficiency, accelerate issue resolution, and strengthen real-time compliance oversight across global markets.
The rollout reflects a broader technology shift underway in the pharmaceutical industry, where manufacturers are increasingly moving away from fragmented and vendor-dependent compliance systems toward unified, AI-enabled traceability platforms offering greater operational control, faster implementation, and enhanced supply chain visibility.
The deployment has already resulted in faster serialization processing, improved packaging floor productivity, and enhanced real-time visibility across export supply chains. These capabilities are becoming increasingly critical as pharmaceutical manufacturers respond to evolving global regulatory mandates and rising supply chain complexity.
“As supply chains become more complex, limited data access in legacy systems is becoming a growing challenge. While technology has advanced, many systems have not kept pace. Today, pharmaceutical companies need solutions that provide greater control over their data and processes. AltiusHub has enabled our teams to manage serialization and traceability workflows with greater transparency, flexibility, and independence,” said Dr Bhaskar Reddy, Director, Hetero Group
“We need systems that give our teams real-time visibility, faster issue resolution, and greater control over compliance workflows. AltiusHub has helped us simplify these operations while improving efficiency across the packaging and dispatch process”, said Sridhar Reddy, Operations Head, Annora Pharma
“For a long time, pharma companies have had to accept that traceability implementations are slow, resource-intensive, and heavily dependent on vendors. AltiusHub’s go-live at Annora Pharma shows that this model is changing. An AI-native solution like AltiusHub delivers speed, scalability, and control while meeting the strict regulatory standards the industry requires,” said Siddharth Reddy, Managing Director, AltiusHub.
Within two years of inception, AltiusHub has enabled serialization and compliance operations across more than 50 regulated markets. These include the United States under DSCSA, the European Union under FMD, Saudi Arabia under SFDA, the UAE under Tatmeen, Russia under Chestny ZNAK, and other export destinations. AltiusHub has also supported pharmaceutical traceability requirements for public health supply programs serving African markets under global healthcare initiatives.